2026-08-04T16:51:55-05:00 2025-12-31 946214841 ARMANINO ADVISORY LLC 50 W SAN FERNANDO ST STE 500 SAN JOSE CA 95113 990 2025-01-01 743100945 VIVA PHYSICIANS INC VIVA 4085133241 400 S FARRELL DRIVE B120 PALM SPRINGS CA 92262 REBECCA HALL EXECUTIVE DIRECTOR 4085133240 2026-08-04 1 MATTHEW PETROSKI P00853132 4082006400 2026-08-04 2025 2025-03-06 01:10:19Z THE VIVA FOUNDATION REBECCA HALL 400 S FARRELL DRIVE B120 PALM SPRINGS CA 92262 7383037 0 X HTTPS://VIVA-FOUNDATION.ORG X 2003 MA TO SYNERGIZE THE COLLECTIVE TALENTS OF THESE RECOGNIZED EXPERTS TO PROMOTE (CONTINUED ON SCH O) AWARENESS AND INNOVATIVE THERAPEUTIC OPTIONS FOR VASCULAR DISEASE 12 0 7 0 0 0 2420000 2312500 3152137 3847039 756970 740299 899 479 6330006 6900317 522530 511000 0 0 1655983 1720412 0 0 18015 3161423 3513595 5339936 5745007 990070 1155310 26199265 29113438 970940 1387081 25228325 27726357 X TO SYNERGIZE THE COLLECTIVE TALENTS OF THESE RECOGNIZED EXPERTS TO PROMOTE AWARENESS AND INNOVATIVE THERAPEUTIC OPTIONS FOR VASCULAR DISEASE 0 0 5350537 511000 3847039 EDUCATIONTHE ORGANIZATION SPONSORS VASCULAR INTERVENTIONAL ADVANCES ("VIVA"), THE GLOBAL EDUCATION COURSE FOR VASCULAR MEDICINE AND INTERVENTION. VIVA IS CONDUCTED ANNUALLY IN LAS VEGAS, NEVADA AND ON A SMALLER SCALE WITH OTHER NONPROFIT ORGANIZATIONS IN A COLLABORATIVE ROLE BOTH DOMESTICALLY AND WORLDWIDE. IN 2025, THE ANNUAL CONFERENCE WAS HOSTED LIVE AND VIRTUALLY, AND SEVERAL EDUCATIONAL WEBINARS WERE HELD THROUGHOUT THE YEAR.VIVA IS SPONSORED BY VPI AND CONTRACTS WITH AN ACCREDITED CONTINUING MEDICAL EDUCATION ("CME") PROVIDER (CONTINUED ON SCHEDULE O)TO APPROVE CREDITS FOR PHYSICIAN ATTENDEES NURSES, TECHS, AND OTHER HEALTHCARE PROFESSIONALS. VIVA FURTHERS VPL'S EXEMPT PURPOSE AS BOTH AN ACCREDITED CONTINUING MEDICAL EDUCATION PROGRAM AND A FORUM FOR PROMOTING THE LATEST RESEARCH FINDINGS AND TECHNOLOGY IN THE FIELD OF VASCULAR MEDICINE AND INTERVENTION.IN 2015, VIVA ADDED A TWO-DAY PROGRAM, THE VEINS (VENOUS ENDOVASCULAR INTERVENTIONAL STRATEGIES), FOCUSED EXCLUSIVELY ON TREATING PATIENTS WITH VENOUS DISEASE. THIS COURSE IS HELD ANNUALLY THE TWO DAYS PRECEDING THE VIVA CONFERENCE. VPI HAS SUPPORTED A MULTIDISCIPLINARY FELLOWSHIP FOR SEVERAL YEARS. IN THE PAST SEVEN YEARS, ADDITIONAL OPPORTUNITIES FOR TRAINING FELLOWS HAVE BEEN INCORPORATED INTO THE ANNUAL VIVA CONFERENCE. BEGINNING IN 2018, VIVA PARTNERED WITH THE AMERICAN HEART ASSOCIATION TO PROVIDE RESEARCH GRANTS FOR FELLOWS AND PLANS TO CONTINUE THIS COLLABORATION THROUGH 2027, AS WELL AS A GRANT FOR A COLLABORATIVE SCIENCES AWARD FOR PATIENT-ORIENTED AND CLINICAL RESEARCH IN VASCULAR SCIENCE.VIVA IS FUNDED PRIMARILY THROUGH UNRESTRICTED EDUCATIONAL GRANTS FROM COMMERCIAL SUPPORTERS IN ACCORDANCE WITH STANDARDS OF THE AMERICAN COUNCIL FOR CONTINUING MEDICAL EDUCATION ("ACCME"). VIVA ALSO GENERATES FUNDS THROUGH REGISTRATION AND TUITION PAYMENTS FROM THE CONFERENCE ATTENDEES.VPI STRIVES TO BE THE PREMIER EDUCATOR IN THE FIELD OF VASCULAR MEDICINE AND INTERVENTION AND TO ASSOCIATE THE NAME "VIVA" WITH CUTTING EDGE AND STATE-OF-THE-ART PROGRAMS THAT SERVE THE PUBLIC GOOD BY PROMOTING ADVANCES IN TREATMENT OF PERIPHERAL VASCULAR DISEASE. IN 2012, VPI EXPANDED ITS INTERNATIONAL EDUCATIONAL OPPORTUNITIES BY COLLABORATING WITH INTERNATIONAL ORGANIZATIONS TO PROVIDE STATE OF THE ART LEARNING MODALITIES AND CUTTING-EDGE PROGRAMS IN COUNTRIES SUCH AS BRAZIL, GERMANY, GREAT BRITAIN, ISRAEL AND CHINA.IN 2014, VPI LAUNCHED A VIRTUAL VIV A APPLICATION THAT MADE IT POSSIBLE FOR INTERNATIONAL AND MILITARY PHYSICIANS TO PARTICIPATE IN THE ANNUAL VIV A CONFERENCE REMOTELY. VIVA OFFERS COMPLIMENTARY ACCESS AND/OR DEEP DISCOUNTS TO EDUCATIONAL CONTENT THROUGH THE VIRTUAL VIVA APP TO INTERNATIONAL PHYSICIANS AS WELL AS ALL ACTIVE MILITARY PHYSICIANS.IN 2025, VPI ENTERED INTO AN AGREEMENT WITH THE MINNEAPOLIS RADIOLOGY AND VASCULAR RESEARCH FOUNDATION TO ASSUME MANAGEMENT OF CARVE - CLINICALLY RELEVANT VASCULAR & ENDOVASCULAR SURGERY, AN EDUCATIONAL CONFERENCE THAT TOOK PLACE FROM MARCH 8, 2026 THROUGH MARCH 11, 2026.RESEARCHVPI SPONSORS RESEARCH AND PIONEERING THERAPY IN THE FIELD OF VASCULAR MEDICINE. VPI RECEIVES GRANTS FROM INDUSTRY AS WELL AS CONTRIBUTIONS FROM PRIVATE INDIVIDUALS IN SUPPORT OF PVD (PERIPHERAL VASCULAR DISEASE) RESEARCH.VPI HAS MANAGED SEVERAL FOOD AND DRUG ADMINISTRATION ("FDA") APPROVED STUDIES RELATED TO PVD TREATMENT. THESE TRIALS FOLLOW GOOD CLINICAL PRACTICE ("GCP") PROTOCOLS AND REQUIRE STRICT INSTITUTIONAL REVIEW BOARD ("IRB") APPROVAL AT EACH SITE. VIVA HAS ALSO PROVIDED SUPPORT FOR NIH APPROVED CLINICAL TRIALS IN THE VASCULAR AND VEINS SPACE.ADVOCACYAS PART OF VPI'S STRATEGIC PLAN, PATIENT CARE ADVOCACY PROGRAMS ARE DESIGNED TO ADVANCE THE FIELD OF VASCULAR DISEASE CARE AND ENGAGE THOUGHT LEADERS AND GOVERNMENT AGENCIES, INCLUDING THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) AND THE CENTERS FOR MEDICARE & MEDICAID SERVICES (CMS).THE FIRST ADVOCACY PROGRAM WAS HELD IN APRIL 2016 AND FOCUSED ON THE GLOBAL MANAGEMENT OF CRITICAL LIMB ISCHEMIA (CLI), ONE OF THE MOST CHALLENGING VASCULAR DISORDERS. A SECOND VASCULAR DISEASE FORUM WAS CONVENED IN MAY 2018, FOCUSING ON THE TREATMENT AND MANAGEMENT OF CAROTID ARTERY DISEASE. A SUBSEQUENT FORUM IN FEBRUARY 2019 ADDRESSED A META-ANALYSIS EVALUATING THE SAFETY OF PACLITAXEL. AS PART OF THIS EFFORT, VPI LED THE ANALYSIS OF PATIENT-LEVEL DATA TO ADDRESS QUESTIONS RELATED TO PATIENT SAFETY; THE FINDINGS WERE SUBSEQUENTLY PUBLISHED IN THE PEER-REVIEWED JOURNAL CIRCULATION.IN 2022, VPI SPONSORED AN ADDITIONAL FORUM ADDRESSING KEY ISSUES RELATED TO VENOUS STENTING AND THROMBECTOMY, WHICH RESULTED IN A PUBLISHED PAPER. IN 2024, VPI HOSTED A VASCULAR LEADERS FORUM FOCUSED ON CHRONIC LIMBTHREATENING ISCHEMIA (CLTI), WHICH PRODUCED TWO PUBLISHED ARTICLES: COLLABORATION IN CONTEMPORARY CLTI CARE AND DESIGNING CLTI CLINICAL TRIALS.THE 2025 FORUM FOCUSED ON ENDOVASCULAR REPAIR FOR AORTIC ANEURYSMS, WITH TWO WHITE PAPERS EXPECTED TO BE PUBLISHED: (1) A PAPER ADDRESSING THE HISTORY AND TERMINOLOGY SURROUNDING "ENDOLEAK, AND (2) A PAPER FOCUSED ON ADVANCING TREATMENT APPROACHES IN THE COMPLEX AORTIC DISEASE SPACE. 5350537 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 117 0 1 7 1 0 0 0 0 0 0 0 0 0 0 0 0 X 12 0 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 MA CA X VIVA PHYSICIANS INC 4085133241 400 S FARRELL DRIVE B120 PALM SPRINGS CA 92262 SAHER SABRI MD BOARD PROGRAM CHAIR 3.00 X X 54250 0 0 KATHLEEN GIBSON MD BOARD PROGRAM CHAIR 3.00 X X 22438 0 0 NITEN SINGH MD BOARD PRESIDENT 3.00 X X 49000 0 0 PARAG PATEL MD BOARD SECRETARY/TREASURER 3.00 X X 40000 0 0 EHRIN ARMSTRONG MD BOARD TRUSTEE 3.00 X 25000 0 0 JOSHUA A BECKMAN MD BOARD TRUSTEE 3.00 X 23000 0 0 VENITA CHANDRA MD BOARD TRUSTEE 3.00 X 18750 0 0 BRIAN DERUBERTIS MD BOARD TRUSTEE 3.00 X 16750 0 0 CHRISTOPHER METZGER MD BOARD TRUSTEE 3.00 X 25000 0 0 ERIC SECEMSKY MD BOARD TRUSTEE 3.00 X 21000 0 0 RAGHU KOLLURI MD BOARD TRUSTEE 3.00 X 25000 0 0 SEAN P LYDEN MD BOARD TRUSTEE 3.00 X 25000 0 0 REBECCA HALL EXECUTIVE DIRECTOR 40.00 X 425659 0 29238 CHRISTOPHER EBBE DIRECTOR OF PROGRAMS 40.00 X 285538 0 33310 THERESA KINANE DIRECTOR OF FINANCE & LOGISTICS 40.00 X 225049 0 19018 BRITA THORNE FACULTY MANAGER 40.00 X 117394 0 12861 1398828 0 94427 4 0 1 0 M EVENTS (FORMERLY ADVANCE CONCEPTS INC 8453N TYCO ROAD VIENNA VA 22182 EVENT PRODUCTION 967509 WYNN LAS VEGAS LLC 3131 S LAS VEGAS BOULEVARD LAS VEGAS NV 89109 HOTEL SERVICES 957931 COMMUNITY BANKERS MERCHANT SERVICESCELE 9550 W HIGGINS RD FLOOR 8 ROSEMONT IL 60018 CREDIT CARD PROCESSING 107351 3 2312500 2312500 TUITION AND FEES - VIV 611430 1729467 1729467 OTHER INCOME - VIVA CO 541700 1113157 1113157 EXHIBIT INCOME - VIVA 541700 1004415 1004415 3847039 733061 733061 479 479 489958 482720 7238 7238 7238 6900317 3847039 0 740778 511000 511000 800085 681631 113664 4790 765558 721967 32241 11350 22625 22625 63174 59726 2460 988 68970 63718 4651 601 3386 3386 57635 57635 100388 100388 263831 262631 1200 15939 15939 339485 332343 7105 37 25374 25216 158 665624 612159 53465 1896476 1896216 260 12350 12348 2 11771 11682 89 FACULTIES' HONORARIA AN 95648 95648 EDITORIAL 25688 25688 5745007 5350537 376455 18015 2552 3537 10626089 12353357 790 81550 20147 44995 100446 29371 83425 71075 15363132 16511345 103130 47579 26199265 29113438 626775 681402 309375 581250 1800 111965 32990 12464 970940 1387081 X 25108210 27644078 120115 82279 25228325 27726357 26199265 29113438 1155310 1342722 0 X 0 1 X 1 0 X 2854000 2781600 2791000 2420000 2312500 13159100 2304071 2714677 2572231 3152137 3847039 14590155 5158071 5496277 5363231 5572137 6159539 27749255 3575120 3036100 3202340 3141653 3232749 16187962 0 3575120 3036100 3202340 3141653 3232749 16187962 11561293 349234 379111 578886 752180 733540 2792951 349234 379111 578886 752180 733540 2792951 5507305 5875388 5942117 6324317 6893079 30542206 0.37850 0.09140 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 96873 26039 70834 3573 3332 241 71075 LEASE LIABILITY 12464 12464 X 8142651 1342722 1342722 6799929 100388 100388 6900317 5644619 0 5644619 100388 100388 5745007 PART X, LINE 2: VIVA PHYSICIANS, INC. IS EXEMPT FROM INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND STATE INCOME TAXES UNDER SECTION 23701(D) OF THE CALIFORNIA REVENUE TAXATION CODE. ACCORDINGLY, NO PROVISION FOR INCOME TAXES HAS BEEN MADE IN THE ACCOMPANYING STATEMENTS. IN ADDITION, THE ORGANIZATION QUALIFIES FOR THE CHARITABLE CONTRIBUTION DEDUCTION UNDER SECTION 170(B)(1)(A) OF THE INTERNAL REVENUE CODE AND HAS BEEN CLASSIFIED AS AN ORGANIZATION THAT IS NOT A PRIVATE FOUNDATION UNDER SECTION 509(A)(1) OF THE INTERNAL REVENUE CODE. GENERALLY ACCEPTED ACCOUNTING PRINCIPLES PROVIDE ACCOUNTING AND DISCLOSURE GUIDANCE ABOUT POSITIONS TAKEN BY AN ORGANIZATION IN ITS TAX RETURNS THAT MIGHT BE UNCERTAIN. MANAGEMENT HAS CONSIDERED ITS TAX POSITIONS AND BELIEVES THAT ALL OF THE POSITIONS TAKEN BY THE ORGANIZATION IN THEIR FEDERAL AND STATE EXEMPT ORGANIZATION TAX RETURNS ARE MORE-LIKELY-THAN-NOT TO BE SUSTAINED UPON EXAMINATION. THE ORGANIZATION FILES INFORMATION RETURNS IN THE U.S. FEDERAL JURISDICTION AND STATES OF MASSACHUSETTS AND CALIFORNIA. THE ORGANIZATION'S FEDERAL RETURNS FOR THE TAX YEARS 2022 AND BEYOND REMAIN SUBJECT TO EXAMINATION BY THE INTERNAL REVENUE SERVICE. THE ORGANIZATION'S CALIFORNIA RETURNS OF THE TAX YEARS 2021 AND BEYOND REMAIN SUBJECT TO EXAMINATION BY THE FRANCHISE TAX BOARD. THE ORGANIZATION'S MASSACHUSETTS RETURNS OF THE TAX YEARS 2022 AND BEYOND REMAIN SUBJECT TO EXAMINATION BY THE COMMONWEALTH OF MASSACHUSETTS OFFICE OF THE ATTORNEY GENERAL. 1 AMERICAN HEART ASSOCIATION INC PO BOX 841750 DALLAS TX 75284 135613797 501(C)(3) 500000 0 CLINICAL RESEARCH THE ROOST FOUNDATION 68718 PALM CANYON DRIVE 203 CATHEDRAL CITY CA 92234 311492063 501(C)(3) 7500 0 SUPPORTING LOCAL CHARITIES 2 0 PART I, LINE 2: THE AMOUNT GIVEN REPORTED ON PART II WERE DONATIONS TO 501(C)(3) ORGANIZATIONS. ALTHOUGH THE FUNDS WILL BE USED BY THE DONEE ORGANIZATIONS FOR RELATED EXEMPT PURPOSE OPERATIONS, VPI DOES NOT MONITOR THE USE OF DONATIONS TO OTHER ORGANIZATIONS. X X X 0 0 0 0 0 0 0 1 0 REBECCA HALL EXECUTIVE DIRECTOR 360659 0 65000 0 0 0 10500 0 18738 0 454897 0 0 0 CHRISTOPHER EBBE DIRECTOR OF PROGRAMS 230538 0 55000 0 0 0 8566 0 24744 0 318848 0 0 0 THERESA KINANE DIRECTOR OF FINANCE & LOGISTICS 213049 0 12000 0 0 0 6751 0 12267 0 244067 0 0 0 PART I, LINE 7 THE EXECUTIVE DIRECTOR AS WELL AS OTHER OFFICERS AND KEY EMPLOYEES ARE ELIGIBLE FOR AN ANNUAL BONUS BASED ON PERFORMANCE. FORM 990, PART VI, SECTION B, LINE 11B MANAGEMENT AND BOARD TREASURER REVIEW COPY OF FORM 990 WITH TAX PREPARER AND THEN A COPY OF THE 990 IS PROVIDED TO THE BOARD THROUGH A SECURE WEB-BASED PORTAL FOR BOARD REVIEW AND COMMENT. FORM 990, PART VI, SECTION B, LINE 12C CONFLICT OF INTEREST POLICY IS AVAILABLE ON THE PORTAL AND BOARD OF DIRECTORS ARE REQUIRED TO UPDATE ANNUALLY AND MORE FREQUENTLY AS CHANGES OCCUR. POLICIES ARE THEN REVIEWED BY THE EXEC. COMMITTEE AND CONFLICTS ARE NOTED AND MANAGED AS THEY RELATE TO BOARD BUSINESS. FORM 990, PART VI, SECTION B, LINE 15 EXECUTIVE DIRECTOR'S COMPENSATION IS REVIEWED ANNUALLY BY THE EXECUTIVE COMMITTEE AND COMPARATIVE SALARY/BENEFIT DATA IS REVIEWED TO ENSURE FMV COMPENSATION. SULLIVAN, COTTER AND ASSOCIATES, INC. (SULLIVANCOTTER), A NATIONALLY-RECOGNIZED COMPENSATION AND BENEFITS CONSULTING FIRM CONDUCTED A COMPENSATION SURVEY TO EVALUATE THE REASONABLENESS OF THE COMPENSATION PAID TO VIVA'S BOARD OF DIRECTORS, INCLUDING THOSE WHO SERVE AS OFFICERS OF THE ORGANIZATION, FOR SERVICES RELATED TO LEADERSHIP, ADMINISTRATION AND EDUCATIONAL/PROFESSIONAL DUTIES AND RESPONSIBILITIES. ACCORDING TO THEIR REPORT, COMPENSATION TO VIVA'S BOARD MEMBERS IS WITHIN COMPETITIVE NORMS FOR ADMINISTRATIVE/LEADERSHIP DUTIES AND RESPONSIBILITIES AND THEREFORE CAN BE CONSIDERED REASONABLE IN RELATION TO THE MARKET DATA. FORM 990, PART VI, SECTION C, LINE 19 CONFLICT OF INTEREST POLICY IS DISCLOSED ANNUALLY AT THE VIVA MEETING IN A PUBLIC FORUM. GOVERNING DOCUMENTS AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST.